Hydralazine Hydrochloride Tablet
Product Images NDC 71205-091

2 FDA label images from Proficient Rx Lp · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Hydralazine Hydrochloride (NDC 71205-091). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

0801cbcc-figure-01 (0801cbcc Figure 01)

0801cbcc-figure-01 (0801cbcc Figure 01)
Chemical structure of Hydralazine Hydrochloride showing a bicyclic aromatic ring connected to a hydrazine group and a nitrogen-nitrogen double bond, associated with hydrochloride (HCl).*
FDA Label Image

71205-091-90 (0801cbcc Figure 02)

71205-091-90 (0801cbcc Figure 02)
Hydralazine HCl 10 mg tablets package label for 90 tablets, labeled RX Only. The label includes the active ingredient Hydralazine Hydrochloride 10 mg per tablet, notes the tablets are orange, round, and debossed with "H" and "38". Manufactured by Hetero Labs Limited, India, and packaged by Proficient Rx LP, Thousand Oaks, CA. Storage instructions are 20°-25°C (68°-77°F).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.